Developer docs
API playgroundTry for free, no card

Search company profiles

Debut

Full company profile

uuid00002b5

Namestring
Debut
Legal namestring
Debut Biotechnology, Inc.
Company typeenum
Private
Founded yearint
2019
Descriptiontext

Debut Biotechnology, Inc. is a San Diego-based, venture-backed biotech beauty company founded in 2019 by Dr. Joshua Britton that combines AI-driven genomics with synthetic biology to discover, manufacture, and commercialize novel, clinically-validated beauty ingredients. The core technology is BeautyORB, a proprietary AI platform trained on 2B+ proprietary skin-health genomic data points that screens 96B+ ingredient possibilities and evaluates 30K genes, 20K molecules per minute, and 200+ biological pathways per discovery cycle. Debut couples BeautyORB to a vertically integrated stack of cell-free biomanufacturing, plant cell biotechnology, and precision fermentation, enabling it to produce rare, agriculturally constrained, or petrochemical-derived ingredients (e.g., Orris fragrance, bio-carmine red pigment, Red 40 food dye alternative) and four commercially launched DermCeutical skincare actives (NAR, DHK, EDL, PNar) targeting the 14 hallmarks of aging.

Debut operates a multi-stream business model. It sells proprietary cosmetic ingredients directly to beauty brands on a quote-based B2B basis (FCA San Diego), offers formulation and contract manufacturing services to beauty brands via the BiotechXBeautyLabs CMO (white-label in ~3 months, custom in ~7 months, no upfront R&D cost, 7,000+ proprietary claims, 95% bio-based formulations), and runs multi-year strategic co-development and supply partnerships with major consumer-goods companies — most notably L'Oréal (a dozen+ bio-identical ingredients), Natura (Latin American skin longevity), and Oterra (food colorants). Distribution is augmented by a wholly-owned consumer sub-brand, DEINDE, which functions as a proof-of-concept for biotech-derived ingredients. Go-to-market is enterprise-led (flagship conglomerate partnerships), supplemented by a B2B brand-partner channel (Formula Fig, Image Skincare) and a CMO/contract-manufacturing channel (KDC/one).

Debut is a Delaware-incorporated private company headquartered in San Diego with disclosed offices/facilities in San Diego, Atlanta (manufacturing), Singapore (regional HQ planned for Asia), and São Paulo (Latin America via Natura). It has raised ~$87M+ in disclosed funding across seed, Series A ($22.6M, 2021, Material Impact-led), Series B ($40M+, 2023, L'Oréal BOLD-led), and a 2025 $20M EDBI/BOLD round, and was named to the TIME100 Most Influential Companies 2025.

Short descriptiontext

Debut Biotechnology is a San Diego-based biotech company that uses its proprietary BeautyORB AI genomics platform and biomanufacturing to discover, validate, and supply novel clinically-validated beauty ingredients to B2B beauty brands, conglomerates (e.g., L'Oréal, Natura, Oterra), and consumers via its DEINDE brand.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersSan Diego, United States
HQ citystring
San Diego
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices4 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
biotech cosmetic ingredients, AI ingredient discovery, cell-free biomanufacturing, precision fermentation ingredients, bio-based beauty formulations
Industry3 codes
PRIMARYCRADAOAO
Ingredient Blends & Systems / Custom Formulation (Seasoning Systems, Functional Blends)
SECONDARYAFAJAKAK
Condition-Specific Bioactives (Glucosamine/Chondroitin, Plant Sterols, Melatonin, Lutein/Zeaxanthin)
Agriculture & Food Production/Food Ingredients & Additives/Nutraceutical & Functional Ingredients (Vitamins, Minerals, Omega-3s, Botanicals)
SECONDARYEUAAAIAJ
Bio-based Food & Flavor Ingredients (Non-fuel Co-products: sweeteners, organic acids, flavors)
Energy, Utilities & Environment/Bioenergy, Natural Gas & Biomass/Biorefining & Bio-based Chemicals (Co-products, Bioproducts)
NAICS code3 codes
  • Medicinal and Botanical Manufacturing325411
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
  • Synthetic Dye and Pigment Manufacturing32513
SIC code2 codes
  • Perfumes, Cosmetics & Other Toilet Preparations2844
  • Medicinal Chemicals & Botanical Products2833
Product category
Biotech Cosmetic Ingredients
GTM motion4 records

Each record includes

Type, Description, Source

Revenue model5 records
1B2B Cosmetic Ingredient Sales
TypeOne Time License
Description

Direct sale of proprietary cosmetic ingredients (e.g., DermCeutical NAR, DHK, EDL, PNar) to beauty brand customers on a per-order basis. Products shipped FCA San Diego; quoted prices fixed for 30 days from quotation; lead times up to ~20 weeks for orders of 10kg or more.

debutbiotech.com
2Contract Manufacturing (CMO) and Formulation Services
TypeProfessional Services
Description

BiotechXBeautyLabs provides formulation development and contract manufacturing to beauty brands, with white-label products in as little as 3 months or custom formulations in 7 months. Includes access to 7,000+ proprietary claims and 95% bio-based formulations. Service revenue tied to formulation/CMO engagements.

prnewswire.com
3Strategic Ingredient Development Partnerships (L'Oréal, Oterra, Natura)
TypeLicensing Royalties
Description

Multi-year strategic co-development partnerships with major consumer goods companies (L'Oréal to develop a dozen+ bio-identical ingredients; Oterra for Red 40 alternative; Natura for AI-discovered skin longevity ingredient for Latin America). Revenue model is contract-based R&D and supply agreements.

americansalon.com
4Direct-to-Consumer Brand (DEINDE)
TypeTransaction Fee
Description

Consumer brand 'DEINDE' launched in 2024 as a biotech beauty proof-of-concept, including products such as the Radiance-Restoring Overnight Mask and the Overnight-Sculpting Face Tape. Generates retail/consumer revenue and serves as a validation platform for Debut's proprietary ingredients.

cosmeticsandtoiletries.com
5B2B Brand Partnerships (e.g., Image Skincare)
TypeTransaction Fee
Description

Debut partners with skincare brands such as Image Skincare to launch products using its proprietary ingredients (e.g., EDL skin-tightening). Brand partners sell finished products; Debut earns ingredient supply revenue.

cnbc.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels6 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales, Supply Chain
Pricing details2 tiers
1Quote-based B2B ingredient pricing (per kg, FCA San Diego)
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Pricing per written quotation valid for 30 days; U.S. dollars; exclusive of taxes, freight, duties. Minimum order quantities may apply with small-order surcharges. Net 30 payment terms; 1.5% per month late interest. Samples are paid, not free.

debutbiotech.com
2BiotechXBeautyLabs CMO/Formulation: project-based, no upfront R&D cost to brand
ModelOtherBilling cadenceMulti-year contract
Notes

Service-based pricing. White-label formulations in ~3 months; custom formulations in ~7 months. Includes access to 7,000+ proprietary claims and 95% bio-based formulations. Project-based engagement.

prnewswire.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 4 records shown
1BiotechXBeautyLabs
Description

Formulation development and contract manufacturing business launched in July 2024 giving beauty brands access to cutting-edge biotech ingredient and formulation innovation with no upfront research cost

prnewswire.com
+3 more records
Core offering1 text field

Debut combines AI-driven ingredient discovery with cell-free biomanufacturing, plant cell biotechnology, and precision fermentation to develop high-performance cosmetic ingredients (DermCeutical NAR, DHK, EDL, PNar), fragrance ingredients (Orris), and natural colorants (Bio-Carmine and a Red 40 alternative) for beauty and personal care brands. The company also operates BiotechXBeautyLabs, a formulation development and contract manufacturing service offering beauty brands white-label or custom biotech-enabled formulations with access to 7,000+ proprietary claims.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 13 values shown
  • EDL clinical study: 100% fine-line improvement rate; 73% skin sagging improvement; six-fold elastin production increase (12 weeks)
+12 more records
Product overview1 text field

Debut operates a vertically integrated platform-plus-modules architecture combining AI and biotechnology to discover, validate, and commercialize high-performance beauty ingredients. The core is the BeautyORB AI discovery platform, which screens 96 billion+ ingredient possibilities against 2 billion proprietary skin health data points and powers the development of all named DermCeutical ingredients (NAR, DHK, EDL, PNar) plus pipeline candidates (DBT-MH, DBT-PS, DBT-DDF, DBT-RR, DBT-NS, DBT-IC). The platform feeds into BiotechXBeautyLabs, the formulation development and contract manufacturing business unit that offers brands access to biotech ingredients via white-label or custom formulations. Debut's commercial ingredients include fragrance ingredients (Orris via plant cell biotechnology), colorants (Bio-Carmine and the Red 40 alternative with Oterra), and topical skin/hair care actives. DEINDE is Debut's own consumer skincare sub-brand serving as proof of concept. Debut also licenses technology and partners with L'Oréal, Natura, KDC/one, and Formula Fig for commercialization.

Product and service9 records
1BeautyORB™ AI Ingredient Discovery Platform
CategoryAI Discovery Platform
Description

AI-powered genomics platform for skin health that screens 96 billion+ ingredient possibilities, leveraging 2 billion proprietary data points, 20,000 molecules screened per minute, and 200+ new pathways evaluated to discover novel, high-performance cosmetic ingredients.

2BiotechXBeautyLabs (CMO/Formulation Service)
CategoryContract Manufacturing / Formulation Service
Description

Formulation development and contract manufacturing business providing beauty brands access to biotech ingredients and custom formulations with no upfront research cost. White label products in ~3 months and custom formulations in ~7 months, with access to 7,000+ proprietary claims and 95% bio-based formulations.

3DermCeutical Naringenin (NAR)
CategoryTopical Skincare Ingredient (DermCeutical line)
Description

Topical skincare ingredient targeting anti-inflammaging; antioxidant that reduces inflammatory markers, strengthens the skin barrier, and scavenges reactive oxygen species. 15x better than niacinamide at reducing inflammaging markers; 100% saw improvement in elasticity and 97% saw improvement in wrinkles.

4DermCeutical DHK
CategoryTopical Skincare Ingredient (DermCeutical line)
Description

Topical skincare ingredient for skin barrier recovery; calms stressed skin, promotes repair, and preserves extracellular matrix integrity. Clinically designed for 2x faster barrier recovery; 81% saw improvement in overall skin appearance.

5DermCeutical EDL
CategoryTopical Skincare Ingredient (DermCeutical line)
Description

Topical skincare ingredient for skin tightening that activates autophagy to reduce sagging and restore a lifted appearance. 100% saw improvement in fine lines; 73% saw improvement in skin sagging; six-fold increase in elastin production in a 12-week study.

6DermCeutical PNar
CategoryTopical Skincare Ingredient (DermCeutical line)
Description

Topical skincare ingredient for hyperpigmentation that intercepts melanin production by blocking key enzymes including tyrosinase. 20.6% improvement in skin radiance after 12 weeks of twice-daily use; competes with kojic acid; EU regulatory compliant.

7Plant Cell Biotechnology Platform — Orris Fragrance Ingredient
CategoryFragrance Ingredient Platform
Description

Plant cell biotechnology platform producing fragrance ingredients without traditional cultivation. Inaugural product is Orris (derived from iris root, valued up to $100,000/kg), which Debut can replicate in under one year versus a five-year traditional maturation cycle.

8Bio-Carmine Red Pigment
CategoryBio-Based Colorant Ingredient
Description

First-ever molecular replica of the vibrant red pigment of carmine, produced via bioproduction as an animal-free alternative to carmine extracted from crushed insects. Targeted for use in food, beverage, and cosmetic applications.

9DEINDE Consumer Skincare Brand
CategoryDTC Consumer Skincare Brand
Description

Consumer biotech skincare brand launched as a proof of concept for Debut's biotech-derived ingredients, backed by Debut's R&D and AI-driven molecule screening. Products include the Radiance-Restoring Overnight Mask and the Overnight-Sculpting Face Tape.

Scale indicator18 records

Each record includes

Type, Value, Description, Source

Partnership7 partners
Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2026-05-27
Description

Strategic partnership to commercialize an AI-discovered skin longevity ingredient complex for the Latin American market. Combines Debut's BeautyORB AI platform (96B molecular possibilities) with Natura's two decades of Amazonian bioactives expertise and 46 socio-biodiversity ingredients. Partnership formalized with offices in San Diego and São Paulo. Products may launch as early as 2027.

Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2026-05-06
Description

Multi-million-dollar, multi-year (3-year) partnership to develop and scale a precision-fermented bio-based alternative to Red 40 food dye. Combines Debut's AI-powered biotech/precision fermentation with Oterra's 150-year heritage and formulation expertise in natural colors. FDA approval being pursued; targeting a $140M global market.

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2025-10-29
Description

Brand partner launching a new skin-tightening product using Debut's proprietary EDL ingredient, scheduled for retail shelves in 2026.

Strategic tierCoreTypeImplementation/ SI/ Consulting PartnerAnnounced on2025-01-28
Description

Contract manufacturing partner for the launch of Debut's BeautyORB AI-powered ingredient discovery platform, enabling biotech innovation access for all beauty brands globally. KDC/one manufactures Debut's biotech ingredients for global commercialization.

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2024-11-12
Description

First professional channel partner signed by BiotechXBeautyLabs™. Collaboration to launch biotech-powered products in the professional beauty services market.

Strategic tierCoreTypeOthersAnnounced on2024-08-12
Description

Debut secured a major defense contract (per Fast Company coverage, August 2024). Details of the contract not specified in the source material.

Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2024-07-02
Description

Strategic partnership to develop and scale biotech-derived ingredients that replace conventionally sourced components in beauty and personal care products. Scope includes more than a dozen synthetic bio-identical ingredients. Disclosed in July 2024 and reported as expanding the original 2023 L'Oréal investment partnership.

Recent move10 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight9 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Checkerspot uses microbial fermentation to produce novel oils and polyols for personal care, beauty, and lifestyle products, making it a directly comparable biotech ingredients platform serving overlapping beauty brand customers.

TypeDirect peer
Description

Conagen is a synthetic biology and precision fermentation company producing high-value ingredients for food, flavor, fragrance, beauty, and pharma — closely mirroring Debut's cell-free and precision fermentation approach to bio-based beauty and food colorant ingredients.

TypeDirect peer
Description

Geltor is an animal-free protein ingredient producer using synthetic biology for beauty and personal care; its fermentation-derived proteins address the same sustainability/ESG-driven replacement of animal-derived cosmetic ingredients that Debut's Bio-Carmine and bio-identical actives target.

TypeDirect peer
Description

Amyris pioneered synthetic biology-derived ingredients for beauty, fragrance, and personal care (e.g., squalane, BioE-Back), and remains the closest historical comp for a fermentation-driven beauty ingredients platform serving mass and prestige beauty brands.

TypeBroad incumbent
Description

Givaudan is the world's largest fragrance and beauty ingredients house and is aggressively expanding into biotech/natural ingredients through its Active Beauty and microbiome platforms — competing with Debut for the same beauty conglomerate customers (L'Oréal, Natura) while offering a much broader portfolio.

TypeBroad incumbent
Description

DSM-Firmenich is a global leader in flavors, fragrances, and beauty ingredients with active investments in biotech and fermentation-derived actives — a broad incumbent competitor to Debut across beauty, food, and nutrition ingredients.

TypeBroad incumbent
Description

BASF's Care Chemicals division supplies bio-based personal care and cosmetic ingredients globally with deep R&D and manufacturing scale; Debut's CSO and Sr. VP Processing both came from BASF/Verenium, underscoring the overlap in technology stack and customer base.

TypeBroad incumbent
Description

IFF's Health & Biosciences unit develops fermentation-derived ingredients for food, beverage, and personal care, directly comparable to Debut's precision fermentation and cell-free biomanufacturing programs (e.g., Red 40 alternative).

TypeBroad incumbent
Description

Symrise is a major flavors, fragrances, and cosmetic ingredients company investing in biotech and sustainable sourcing — overlapping with Debut's fragrance (Orris) and skincare active ingredients portfolios across global beauty conglomerate customers.

TypeBroad incumbent
Description

Robertet is a leading natural fragrance and flavor ingredients house with deep expertise in plant-derived and biotechnologically-produced aroma chemicals — comparable to Debut's plant cell biotechnology platform (e.g., Orris) and broader fragrance ingredient pipeline.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers7 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration1 record

Each record includes

Title, Type, Description, Source

AI capability9 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles9 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries3 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds5 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors17 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Debut

Biotech Cosmetic Ingredientsdebutbiotech.com

Debut Biotechnology is a San Diego-based biotech company that uses its proprietary BeautyORB AI genomics platform and biomanufacturing to discover, validate, and supply novel clinically-validated beauty ingredients to B2B beauty brands, conglomerates (e.g., L'Oréal, Natura, Oterra), and consumers via its DEINDE brand.

What Debut does

Debut Biotechnology, Inc. is a San Diego-based, venture-backed biotech beauty company founded in 2019 by Dr. Joshua Britton that combines AI-driven genomics with synthetic biology to discover, manufacture, and commercialize novel, clinically-validated beauty ingredients. The core technology is BeautyORB, a proprietary AI platform trained on 2B+ proprietary skin-health genomic data points that screens 96B+ ingredient possibilities and evaluates 30K genes, 20K molecules per minute, and 200+ biological pathways per discovery cycle. Debut couples BeautyORB to a vertically integrated stack of cell-free biomanufacturing, plant cell biotechnology, and precision fermentation, enabling it to produce rare, agriculturally constrained, or petrochemical-derived ingredients (e.g., Orris fragrance, bio-carmine red pigment, Red 40 food dye alternative) and four commercially launched DermCeutical skincare actives (NAR, DHK, EDL, PNar) targeting the 14 hallmarks of aging.

Debut operates a multi-stream business model. It sells proprietary cosmetic ingredients directly to beauty brands on a quote-based B2B basis (FCA San Diego), offers formulation and contract manufacturing services to beauty brands via the BiotechXBeautyLabs CMO (white-label in ~3 months, custom in ~7 months, no upfront R&D cost, 7,000+ proprietary claims, 95% bio-based formulations), and runs multi-year strategic co-development and supply partnerships with major consumer-goods companies — most notably L'Oréal (a dozen+ bio-identical ingredients), Natura (Latin American skin longevity), and Oterra (food colorants). Distribution is augmented by a wholly-owned consumer sub-brand, DEINDE, which functions as a proof-of-concept for biotech-derived ingredients. Go-to-market is enterprise-led (flagship conglomerate partnerships), supplemented by a B2B brand-partner channel (Formula Fig, Image Skincare) and a CMO/contract-manufacturing channel (KDC/one).

Debut is a Delaware-incorporated private company headquartered in San Diego with disclosed offices/facilities in San Diego, Atlanta (manufacturing), Singapore (regional HQ planned for Asia), and São Paulo (Latin America via Natura). It has raised ~$87M+ in disclosed funding across seed, Series A ($22.6M, 2021, Material Impact-led), Series B ($40M+, 2023, L'Oréal BOLD-led), and a 2025 $20M EDBI/BOLD round, and was named to the TIME100 Most Influential Companies 2025.

Debut firmographics

Firmographics
Name
Debut
Legal name
Debut Biotechnology, Inc.
Website
https://debutbiotech.com
Company type
Private
Founded year
2019
Operating status
Operating
Headcount range
51–100 employees
Short description
Debut Biotechnology is a San Diego-based biotech company that uses its proprietary BeautyORB AI genomics platform and biomanufacturing to discover, validate, and supply novel clinically-validated beauty ingredients to B2B beauty brands, conglomerates (e.g., L'Oréal, Natura, Oterra), and consumers via its DEINDE brand.
Ownership category
akta.pro rank

Debut industry classification

Industry
Product category
Biotech Cosmetic Ingredients
NAICS
Medicinal and Botanical Manufacturing (325411), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Synthetic Dye and Pigment Manufacturing (32513)
SIC
Perfumes, Cosmetics & Other Toilet Preparations (2844), Medicinal Chemicals & Botanical Products (2833)
akta.pro industry
PRIMARYCRADAOAO
Ingredient Blends & Systems / Custom Formulation (Seasoning Systems, Functional Blends)
SECONDARYAFAJAKAK
Condition-Specific Bioactives (Glucosamine/Chondroitin, Plant Sterols, Melatonin, Lutein/Zeaxanthin)
Agriculture & Food Production/Food Ingredients & Additives/Nutraceutical & Functional Ingredients (Vitamins, Minerals, Omega-3s, Botanicals)
SECONDARYEUAAAIAJ
Bio-based Food & Flavor Ingredients (Non-fuel Co-products: sweeteners, organic acids, flavors)
Energy, Utilities & Environment/Bioenergy, Natural Gas & Biomass/Biorefining & Bio-based Chemicals (Co-products, Bioproducts)

Keywords

  • Biotech cosmetic ingredients
  • AI ingredient discovery
  • Cell-free biomanufacturing
  • Precision fermentation ingredients
  • Bio-based beauty formulations

Where Debut is headquartered

Location

Headquarters

HQ city
San Diego
HQ country
United States
HQ region
North America

Offices4 records

Markets served

Debut business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales, Supply Chain

Revenue model

  1. B2B Cosmetic Ingredient Sales: Direct sale of proprietary cosmetic ingredients (e.g., DermCeutical NAR, DHK, EDL, PNar) to beauty brand customers on a per-order basis. Products shipped FCA San Diego; quoted prices fixed for 30 days from quotation; lead times up to ~20 weeks for orders of 10kg or more.
  2. Contract Manufacturing (CMO) and Formulation Services: BiotechXBeautyLabs provides formulation development and contract manufacturing to beauty brands, with white-label products in as little as 3 months or custom formulations in 7 months. Includes access to 7,000+ proprietary claims and 95% bio-based formulations. Service revenue tied to formulation/CMO engagements.
  3. Strategic Ingredient Development Partnerships (L'Oréal, Oterra, Natura): Multi-year strategic co-development partnerships with major consumer goods companies (L'Oréal to develop a dozen+ bio-identical ingredients; Oterra for Red 40 alternative; Natura for AI-discovered skin longevity ingredient for Latin America). Revenue model is contract-based R&D and supply agreements.
  4. Direct-to-Consumer Brand (DEINDE): Consumer brand 'DEINDE' launched in 2024 as a biotech beauty proof-of-concept, including products such as the Radiance-Restoring Overnight Mask and the Overnight-Sculpting Face Tape. Generates retail/consumer revenue and serves as a validation platform for Debut's proprietary ingredients.
  5. B2B Brand Partnerships (e.g., Image Skincare): Debut partners with skincare brands such as Image Skincare to launch products using its proprietary ingredients (e.g., EDL skin-tightening). Brand partners sell finished products; Debut earns ingredient supply revenue.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goQuote-based B2B ingredient pricing (per kg, FCA San Diego)
OtherMulti-year contractBiotechXBeautyLabs CMO/Formulation: project-based, no upfront R&D cost to brand

Go-to-market motion4 records

Distribution channels6 records

Marketing channels8 records

Debut product offering

Product offering

Core offering

Debut combines AI-driven ingredient discovery with cell-free biomanufacturing, plant cell biotechnology, and precision fermentation to develop high-performance cosmetic ingredients (DermCeutical NAR, DHK, EDL, PNar), fragrance ingredients (Orris), and natural colorants (Bio-Carmine and a Red 40 alternative) for beauty and personal care brands. The company also operates BiotechXBeautyLabs, a formulation development and contract manufacturing service offering beauty brands white-label or custom biotech-enabled formulations with access to 7,000+ proprietary claims.

Product overview

Debut operates a vertically integrated platform-plus-modules architecture combining AI and biotechnology to discover, validate, and commercialize high-performance beauty ingredients. The core is the BeautyORB AI discovery platform, which screens 96 billion+ ingredient possibilities against 2 billion proprietary skin health data points and powers the development of all named DermCeutical ingredients (NAR, DHK, EDL, PNar) plus pipeline candidates (DBT-MH, DBT-PS, DBT-DDF, DBT-RR, DBT-NS, DBT-IC). The platform feeds into BiotechXBeautyLabs, the formulation development and contract manufacturing business unit that offers brands access to biotech ingredients via white-label or custom formulations. Debut's commercial ingredients include fragrance ingredients (Orris via plant cell biotechnology), colorants (Bio-Carmine and the Red 40 alternative with Oterra), and topical skin/hair care actives. DEINDE is Debut's own consumer skincare sub-brand serving as proof of concept. Debut also licenses technology and partners with L'Oréal, Natura, KDC/one, and Formula Fig for commercialization.

Differentiator

Problem solved

Functional benefit

Brands

  • BiotechXBeautyLabs: Formulation development and contract manufacturing business launched in July 2024 giving beauty brands access to cutting-edge biotech ingredient and formulation innovation with no upfront research cost
  • DEINDE
  • BeautyORB
  • DermCeutical

Products and services

  • BeautyORB™ AI Ingredient Discovery Platform AI-powered genomics platform for skin health that screens 96 billion+ ingredient possibilities, leveraging 2 billion proprietary data points, 20,000 molecules screened per minute, and 200+ new pathways evaluated to discover novel, high-performance cosmetic ingredients.
  • BiotechXBeautyLabs (CMO/Formulation Service) Formulation development and contract manufacturing business providing beauty brands access to biotech ingredients and custom formulations with no upfront research cost. White label products in ~3 months and custom formulations in ~7 months, with access to 7,000+ proprietary claims and 95% bio-based formulations.
  • DermCeutical Naringenin (NAR) Topical skincare ingredient targeting anti-inflammaging; antioxidant that reduces inflammatory markers, strengthens the skin barrier, and scavenges reactive oxygen species. 15x better than niacinamide at reducing inflammaging markers; 100% saw improvement in elasticity and 97% saw improvement in wrinkles.
  • DermCeutical DHK Topical skincare ingredient for skin barrier recovery; calms stressed skin, promotes repair, and preserves extracellular matrix integrity. Clinically designed for 2x faster barrier recovery; 81% saw improvement in overall skin appearance.
  • DermCeutical EDL Topical skincare ingredient for skin tightening that activates autophagy to reduce sagging and restore a lifted appearance. 100% saw improvement in fine lines; 73% saw improvement in skin sagging; six-fold increase in elastin production in a 12-week study.
  • DermCeutical PNar Topical skincare ingredient for hyperpigmentation that intercepts melanin production by blocking key enzymes including tyrosinase. 20.6% improvement in skin radiance after 12 weeks of twice-daily use; competes with kojic acid; EU regulatory compliant.
  • Plant Cell Biotechnology Platform — Orris Fragrance Ingredient Plant cell biotechnology platform producing fragrance ingredients without traditional cultivation. Inaugural product is Orris (derived from iris root, valued up to $100,000/kg), which Debut can replicate in under one year versus a five-year traditional maturation cycle.
  • Bio-Carmine Red Pigment First-ever molecular replica of the vibrant red pigment of carmine, produced via bioproduction as an animal-free alternative to carmine extracted from crushed insects. Targeted for use in food, beverage, and cosmetic applications.
  • DEINDE Consumer Skincare Brand Consumer biotech skincare brand launched as a proof of concept for Debut's biotech-derived ingredients, backed by Debut's R&D and AI-driven molecule screening. Products include the Radiance-Restoring Overnight Mask and the Overnight-Sculpting Face Tape.

Quantifiable outcome

  • EDL clinical study: 100% fine-line improvement rate; 73% skin sagging improvement; six-fold elastin production increase (12 weeks)
  • +12 more outcomes

Companies that use Debut

Customer profile

Named customers7 records

Segments5 records

Ideal customer profiles5 records

Debut technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability9 records

Feature8 records

Debut partnerships and signals

Strategic signal

Partnerships

Seven partnerships are on record, tiered flagship and core.

  • Natura (Natura Cosméticos S.A.)flagshipStrategic or Co-development Partner · 27 May 2026Strategic partnership to commercialize an AI-discovered skin longevity ingredient complex for the Latin American market. Combines Debut's BeautyORB AI platform (96B molecular possibilities) with Natura's two decades of Amazonian bioactives expertise and 46 socio-biodiversity ingredients. Partnership formalized with offices in San Diego and São Paulo. Products may launch as early as 2027.
  • OterraflagshipStrategic or Co-development Partner · 6 May 2026Multi-million-dollar, multi-year (3-year) partnership to develop and scale a precision-fermented bio-based alternative to Red 40 food dye. Combines Debut's AI-powered biotech/precision fermentation with Oterra's 150-year heritage and formulation expertise in natural colors. FDA approval being pursued; targeting a $140M global market.
  • Image SkincarecoreChannel Partner/ Reseller/ Distributor · 29 October 2025Brand partner launching a new skin-tightening product using Debut's proprietary EDL ingredient, scheduled for retail shelves in 2026.
  • KDC/onecoreImplementation/ SI/ Consulting Partner · 28 January 2025Contract manufacturing partner for the launch of Debut's BeautyORB AI-powered ingredient discovery platform, enabling biotech innovation access for all beauty brands globally. KDC/one manufactures Debut's biotech ingredients for global commercialization.
  • Formula FigcoreChannel Partner/ Reseller/ Distributor · 12 November 2024First professional channel partner signed by BiotechXBeautyLabs™. Collaboration to launch biotech-powered products in the professional beauty services market.
  • U.S. Department of Defense (Defense Innovation Unit)coreOthers · 12 August 2024Debut secured a major defense contract (per Fast Company coverage, August 2024). Details of the contract not specified in the source material.
  • L'Oréal GroupeflagshipStrategic or Co-development Partner · 2 July 2024Strategic partnership to develop and scale biotech-derived ingredients that replace conventionally sourced components in beauty and personal care products. Scope includes more than a dozen synthetic bio-identical ingredients. Disclosed in July 2024 and reported as expanding the original 2023 L'Oréal investment partnership.

Scale indicators18 records

Recent moves10 records

Expansion highlights9 records

Debut competitors and assessment

Company assessment

Direct peers

  • Checkerspot: Checkerspot uses microbial fermentation to produce novel oils and polyols for personal care, beauty, and lifestyle products, making it a directly comparable biotech ingredients platform serving overlapping beauty brand customers.
  • Conagen: Conagen is a synthetic biology and precision fermentation company producing high-value ingredients for food, flavor, fragrance, beauty, and pharma — closely mirroring Debut's cell-free and precision fermentation approach to bio-based beauty and food colorant ingredients.
  • Geltor: Geltor is an animal-free protein ingredient producer using synthetic biology for beauty and personal care; its fermentation-derived proteins address the same sustainability/ESG-driven replacement of animal-derived cosmetic ingredients that Debut's Bio-Carmine and bio-identical actives target.
  • Amyris (ingredients business): Amyris pioneered synthetic biology-derived ingredients for beauty, fragrance, and personal care (e.g., squalane, BioE-Back), and remains the closest historical comp for a fermentation-driven beauty ingredients platform serving mass and prestige beauty brands.

Broad incumbents

  • Givaudan: Givaudan is the world's largest fragrance and beauty ingredients house and is aggressively expanding into biotech/natural ingredients through its Active Beauty and microbiome platforms — competing with Debut for the same beauty conglomerate customers (L'Oréal, Natura) while offering a much broader portfolio.
  • DSM-Firmenich: DSM-Firmenich is a global leader in flavors, fragrances, and beauty ingredients with active investments in biotech and fermentation-derived actives — a broad incumbent competitor to Debut across beauty, food, and nutrition ingredients.
  • BASF (Care Chemicals division): BASF's Care Chemicals division supplies bio-based personal care and cosmetic ingredients globally with deep R&D and manufacturing scale; Debut's CSO and Sr. VP Processing both came from BASF/Verenium, underscoring the overlap in technology stack and customer base.
  • IFF (Health & Biosciences): IFF's Health & Biosciences unit develops fermentation-derived ingredients for food, beverage, and personal care, directly comparable to Debut's precision fermentation and cell-free biomanufacturing programs (e.g., Red 40 alternative).
  • Symrise: Symrise is a major flavors, fragrances, and cosmetic ingredients company investing in biotech and sustainable sourcing — overlapping with Debut's fragrance (Orris) and skincare active ingredients portfolios across global beauty conglomerate customers.
  • Robertet: Robertet is a leading natural fragrance and flavor ingredients house with deep expertise in plant-derived and biotechnologically-produced aroma chemicals — comparable to Debut's plant cell biotechnology platform (e.g., Orris) and broader fragrance ingredient pipeline.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

Debut social profiles

Digital presence

Debut compliance and trust

Trust signal

Compliance1 record

Debut financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Debut leadership team

Management profile

Number of profiles

Profiles9 records

Debut subsidiaries and ownership

Company hierarchy

Subsidiaries3 records

Debut funding detail

Funding detail

Funding overview

Funding rounds5 records

Investors17 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Debut M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Debut

What does Debut do?

Debut combines AI-driven ingredient discovery with cell-free biomanufacturing, plant cell biotechnology, and precision fermentation to develop high-performance cosmetic ingredients (DermCeutical NAR, DHK, EDL, PNar), fragrance ingredients (Orris), and natural colorants (Bio-Carmine and a Red 40 alternative) for beauty and personal care brands. The company also operates BiotechXBeautyLabs, a formulation development and contract manufacturing service offering beauty brands white-label or custom biotech-enabled formulations with access to 7,000+ proprietary claims.

Is Debut a public or private company?

Debut is a private company. It is classified as venture growth investor backed and is currently operating.

When was Debut founded?

Debut was founded in 2019. It employs 51 to 100 people.

Where is Debut based?

Debut is headquartered in San Diego, United States, in the North America region.

How does Debut make money?

Five revenue lines are on record. B2B Cosmetic Ingredient Sales are the primary driver. The others are contract Manufacturing (CMO) and Formulation Services, strategic Ingredient Development Partnerships (L'Oréal, Oterra, Natura), direct-to-Consumer Brand (DEINDE) and B2B Brand Partnerships (e.g., Image Skincare).

Who are Debut's main competitors?

Direct peers on record are Checkerspot, Conagen, Geltor and Amyris (ingredients business). Broad incumbents are Givaudan, DSM-Firmenich, BASF (Care Chemicals division), IFF (Health & Biosciences), Symrise and Robertet.

Does Debut have an API?

No public API is recorded for Debut.

What industry is Debut in?

Debut's product category is Biotech Cosmetic Ingredients. Its primary akta.pro industry code is CRADAOAO, Ingredient Blends & Systems / Custom Formulation (Seasoning Systems, Functional Blends), with a secondary code of AFAJAKAK, Condition-Specific Bioactives (Glucosamine/Chondroitin, Plant Sterols, Melatonin, Lutein/Zeaxanthin). Its NAICS code is 325411 and its SIC code is 2844.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Longevity.TechnologyWhy the future of skin longevity belongs to generative bio-platformsGenerative AI is re-engineering skin rejuvenation by designing functional collagen from scratch, overcoming animal-derived and recombinant limitations. Cambrium's AI-driven pipeline achieves a 90% secretion success rate versus 5% with conventional methods. Capital is shifting toward AI-backed discovery, with Debut raising $20 million in August 2025.Third NewsDebut Unveils Innovative Biotech Ingredient for Treating HyperpigmentationDebut unveiled DermCeutical PNar™, a biotech ingredient for hyperpigmentation, which blocks tyrosinase at 0.45% concentration. A 12-week study showed 97% of participants improved, and 88% saw brighter skin. The product is now available to brand partners in the U.S.PR NewswireDebut Engineers New Biotech Ingredient for HyperpigmentationDebut launched PNar™, a biotech active for hyperpigmentation correction at a 0.45% use level, less than half the EU's maximum for kojic acid. A 12-week study showed 97% of users improved in hyperpigmentation and 88% in skin brightening. The ingredient is now available to brand partners in the US.Cosmetics & ToiletriesIndustry Insights: Q&A with Debut Biotech’s CEO Joshua BrittonDebut, a biotechnology company founded in 2019, uses AI and genomics to develop innovative ingredients for the beauty industry, focusing on skincare, hair care, and color cosmetics. The company leverages its proprietary platform, BeautyORB, and its AI-driven approach to accelerate discovery, targeting biological pathways for more effective and sustainable products. It aims to revolutionize the industry by enabling precise, biology-based solutions and expanding into personalized and high-performance beauty categories.Longevity.TechnologyAI meets Amazon in longevity beauty pushBiotech company Debut has partnered with Brazilian beauty giant Natura to commercialize an AI-discovered skin longevity ingredient for the Latin American market, with products potentially launching as early as 2027. Debut's AI platform can evaluate up to 96 billion molecular combinations in days, a process estimated to take 125,000 years using conventional screening methods. The collaboration combines Debut's biotechnology platform with Natura's 25 years of experience working with bioactive plants sourced from Amazon rainforest communities, representing a convergence of AI and nature in the beauty industry's shift from 'anti-aging' to 'longevity' products.Global Cosmetics NewsDebut and Natura partner on AI-discovered skin longevity ingredient for Latin AmericaBiotech beauty company Debut and Natura have announced a strategic partnership to commercialize an AI-discovered skin longevity ingredient complex for the Latin American beauty market, combining Debut's AI-powered ingredient discovery platform with Natura's Amazonian bioactives expertise. The companies plan to develop clinically validated products using Debut's biotechnology-derived actives and Natura's botanical ingredients sourced from the Amazon, with potential launches as early as 2027. The partnership marks Debut's entry into the Latin American market and aligns with growing industry investment in AI-driven ingredient innovation and longevity-focused beauty solutions.BriefglanceBeauty's New Formula: AI and Amazonian Botanicals UniteDebut, a San Diego-based biotech beauty firm, and Natura, Brazil's largest cosmetics company, have announced a strategic partnership to develop and commercialize a novel skin longevity ingredient complex using AI-driven molecular discovery combined with sustainably sourced Amazonian botanicals. Debut's proprietary AI platform can screen 96 billion molecular possibilities in days or weeks, a task that would take approximately 125,000 years using conventional screening methods. The collaboration aims to launch products targeting the Brazilian anti-aging market, which was valued at over USD 1 billion in 2024 and is projected to more than double by 2033, with potential market entry as early as 2027.SdbnDebut and Natura Partner to Commercialize AI-Discovered Skin Longevity Ingredient for Latin America – San Diego Biotechnology NetworkDebut and Natura have announced a partnership to commercialize an AI-discovered skin longevity ingredient for the Latin American market. The collaboration combines Debut's AI-powered biotechnology platform with Natura's expertise in Amazonian bioactives to develop longevity-driven beauty products. The partnership was formalized with offices in San Diego and São Paulo, targeting the next generation of AI-biotech beauty innovation in the region.BloombergNatura (NATU3 BZ) Teams Up With Debut to Launch AI-Developed Beauty Products - BloombergNatura Cosmeticos SA announced a partnership with San Diego-based Debut to develop AI-formulated skincare products using proprietary plant-based ingredients, planned for launch in 2027. Debut, a biotechnology company combining AI and beauty technology with investors including L'Oréal SA, will work with Natura to create the new product line. The collaboration represents Natura's strategic push to leverage artificial intelligence for innovation with its existing portfolio of botanical ingredients.PR NewswireDebut and Natura Partner to Commercialize AI-Discovered Skin Longevity Ingredient for Latin AmericaDebut, a biotech beauty company leveraging AI for ingredient discovery, and Natura, a Brazilian multinational beauty company, have announced a strategic partnership to commercialize an AI-discovered skin longevity ingredient complex for the Latin American market. The collaboration combines Debut's AI platform, which can screen 96 billion molecular possibilities in days compared to an estimated 125,000 years via conventional methods, with Natura's two decades of expertise in Amazonian bioactives, with products potentially launching in 2027. The partnership marks Debut's entry into Latin America—the world's fourth-largest beauty market—while positioning both companies at the forefront of AI-powered biotechnology in the beauty industry.